Home » Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Feb 02, 2009

NEW YORK (GenomeWeb News) — Oxford Expression Technologies and Eden Biodesign have struck a co-marketing agreement to serve pharmaceutical researchers involved in protein expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Proteomics & Protein Research

  1. FDA and NCI Memorandum Indicates Growing Interest in Proteogenomics as Clinical Approach

    Premium

  2. NCI, FDA Sign MOU on Proteogenomics Research

  3. WUSTL Team Develops Blood-Based Test for Brain Amyloidosis

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.